Rang	Name	Position
1	Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.	Co-Founder & Executive Chairman
2	Ms. Margaret Alexander	CEO, President & Director
3	Mr. Jeffrey A. Rona	Advisor
4	Mr. Charles Ross Carter M.B.A., M.S.	CFO, Principal Financial Officer, Principal Accounting Officer & Secretary
5	Dr. Zhong Zhong Ph.D.	Chief Scientific Officer
6	Dr. Julia Tsai Ph.D.	Senior Vice President of Clinical Development
7	Dr. Toshiya Nishi D.V.M.	Head of Epilepsy Research
8	Dr. Manal Morsy M.B.A., M.D., PH.D.	Chief Regulatory Officer
9	Ms. Victoria Fort	Chief Strategy Officer
10	Dr. Petra Kaufmann M.D., M.S.	Chief Medical Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Eventide Asset Management, LLC	6,05%	31,78 Mio. USD
2	HHG PLC	5,49%	28,82 Mio. USD
3	RA Capital Management, LLC	5,49%	28,82 Mio. USD
4	Affinity Asset Advisors, LLC	5,19%	27,29 Mio. USD
5	Adage Capital Partners Gp LLC	3,16%	16,58 Mio. USD
6	Federated Hermes Inc	3,05%	16,01 Mio. USD
7	Balyasny Asset Management LLC	2,83%	14,88 Mio. USD
8	Vanguard Capital Management, LLC	2,69%	14,15 Mio. USD
9	ADAR1 Capital Management LLC	2,33%	12,22 Mio. USD
10	Ikarian Capital, LLC	1,48%	7,79 Mio. USD
11	Susquehanna International Group, LLP	1,00%	5,24 Mio. USD
12	Sphera Funds Management Ltd.	0,83%	4,37 Mio. USD
13	BlackRock Inc	0,79%	4,13 Mio. USD
14	Point72 Asset Management, L.P.	0,68%	3,55 Mio. USD
15	Geode Capital Management, LLC	0,67%	3,55 Mio. USD
16	Propel Bio Management LLC	0,57%	3,00 Mio. USD
17	Rosalind Advisors, Inc.	0,57%	2,98 Mio. USD
18	Renaissance Technologies Corp	0,57%	2,97 Mio. USD
19	Sio Capital Management, LLC	0,51%	2,71 Mio. USD
20	SILVERARC CAPITAL MANAGEMENT, LLC	0,51%	2,69 Mio. USD